| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2024 |
Stutzmann GE, Soboloff J. Channelling calcium signals to therapeutics. The Journal of Physiology. PMID 38578234 DOI: 10.1113/JP286421 |
0.01 |
|
| 2023 |
Gautier MK, Kelley CM, Lee SH, Alldred MJ, McDaid J, Mufson EJ, Stutzmann GE, Ginsberg SD. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of down syndrome and Alzheimer's disease. Neurobiology of Disease. 106332. PMID 37890559 DOI: 10.1016/j.nbd.2023.106332 |
0.01 |
|
| 2023 |
Bazarek SF, Thaqi M, King P, Mehta AR, Patel R, Briggs CA, Reisenbigler E, Yousey JE, Miller EA, Stutzmann GE, Marr RA, Peterson DA. Engineered neurogenesis in naïve adult rat cortex by Ngn2-mediated neuronal reprogramming of resident oligodendrocyte progenitor cells. Frontiers in Neuroscience. 17: 1237176. PMID 37662111 DOI: 10.3389/fnins.2023.1237176 |
0.01 |
|
| 2023 |
Webber EK, Fivaz M, Stutzmann GE, Griffioen G. Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37132525 DOI: 10.1002/alz.13065 |
0.01 |
|
| 2022 |
Rozenfeld M, Azoulay IS, Ben Kasus Nissim T, Stavsky A, Melamed M, Stutzmann G, Hershfinkel M, Kofman O, Sekler I. Essential role of the mitochondrial Na/Ca exchanger NCLX in mediating PDE2-dependent neuronal survival and learning. Cell Reports. 41: 111772. PMID 36476859 DOI: 10.1016/j.celrep.2022.111772 |
0.01 |
|
| 2022 |
Wiseman AL, Briggs CA, Peritt A, Kapecki N, Peterson DA, Shim SS, Stutzmann GE. Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model. Journal of Alzheimer's Disease : Jad. PMID 36442195 DOI: 10.3233/JAD-220758 |
0.01 |
|
| 2022 |
Mustaly-Kalimi S, Gallegos W, Marr RA, Gilman-Sachs A, Peterson DA, Sekler I, Stutzmann GE. Protein mishandling and impaired lysosomal proteolysis generated through calcium dysregulation in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 119: e2211999119. PMID 36442130 DOI: 10.1073/pnas.2211999119 |
0.01 |
|
| 2022 |
Stoler O, Stavsky A, Khrapunsky Y, Melamed I, Stutzmann G, Gitler D, Sekler I, Fleidervish I. Frequency- and spike-timing-dependent mitochondrial Ca signaling regulates the metabolic rate and synaptic efficacy in cortical neurons. Elife. 11. PMID 35192454 DOI: 10.7554/eLife.74606 |
0.01 |
|
| 2021 |
Alldred MJ, Lee SH, Stutzmann GE, Ginsberg SD. Oxidative Phosphorylation Is Dysregulated Within the Basocortical Circuit in a 6-month old Mouse Model of Down Syndrome and Alzheimer's Disease. Frontiers in Aging Neuroscience. 13: 707950. PMID 34489678 DOI: 10.3389/fnagi.2021.707950 |
0.01 |
|
| 2021 |
Christian DT, Stefanik MT, Bean LA, Loweth JA, Wunsch AM, Funke JR, Briggs CA, Lyons J, Neal D, Milovanovic M, D'Souza GX, Stutzmann GE, Nicholson DA, Tseng KY, Wolf ME. GluN3-containing NMDA receptors in the rat nucleus accumbens core contribute to incubation of cocaine craving. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34413203 DOI: 10.1523/JNEUROSCI.0406-21.2021 |
0.01 |
|
| 2021 |
McDaid J, Briggs CA, Barrington NM, Peterson DA, Kozlowski DA, Stutzmann GE. Sustained Hippocampal Synaptic Pathophysiology Following Single and Repeated Closed-Head Concussive Impacts. Frontiers in Cellular Neuroscience. 15: 652721. PMID 33867941 DOI: 10.3389/fncel.2021.652721 |
0.01 |
|
| 2021 |
Stutzmann GE. RyR2 calcium channels in the spotlight-I'm ready for my close up, Dr. Alzheimer! Cell Calcium. 94: 102342. PMID 33444912 DOI: 10.1016/j.ceca.2020.102342 |
0.01 |
|
| 2020 |
McDaid J, Mustaly-Kalimi S, Stutzmann GE. Ca Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer's Disease. Cells. 9. PMID 33321866 DOI: 10.3390/cells9122655 |
0.01 |
|
| 2020 |
Chakroborty S, Manfredsson FP, Dec AM, Campbell PW, Stutzmann GE, Beaumont V, West AR. Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington's Disease. Frontiers in Neuroscience. 14: 466. PMID 32581668 DOI: 10.3389/Fnins.2020.00466 |
0.01 |
|
| 2020 |
Schrank S, McDaid J, Briggs CA, Mustaly-Kalimi S, Brinks D, Houcek A, Singer O, Bottero V, Marr RA, Stutzmann GE. Human-Induced Neurons from Presenilin 1 Mutant Patients Model Aspects of Alzheimer's Disease Pathology. International Journal of Molecular Sciences. 21. PMID 32033164 DOI: 10.3390/Ijms21031030 |
0.01 |
|
| 2020 |
Chakroborty S, Manfredsson FP, Dec AM, Campbell PW, Stutzmann GE, Beaumont V, West AR. Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington’s Disease Frontiers in Neuroscience. 14. DOI: 10.3389/fnins.2020.00466 |
0.01 |
|
| 2020 |
Mustaly SH, Beaman KD, Gilman‐Sachs A, Schrank S, Marr R, Stutzmann GE. Lysosome‐autophagosome defects mediate proteinopathy in early stages of Alzheimer’s disease Alzheimer's & Dementia. 16. DOI: 10.1002/alz.047708 |
0.01 |
|
| 2019 |
Schrank S, Barrington N, Stutzmann GE. Calcium-Handling Defects and Neurodegenerative Disease. Cold Spring Harbor Perspectives in Biology. PMID 31427373 DOI: 10.1101/cshperspect.a035212 |
0.01 |
|
| 2019 |
Chakroborty S, Hill ES, Christian DT, Helfrich R, Riley S, Schneider C, Kapecki N, Mustaly-Kalimi S, Seiler FA, Peterson DA, West AR, Vertel BM, Frost WN, Stutzmann GE. Reduced presynaptic vesicle stores mediate cellular and network plasticity defects in an early-stage mouse model of Alzheimer's disease. Molecular Neurodegeneration. 14: 7. PMID 30670054 DOI: 10.1186/S13024-019-0307-7 |
0.01 |
|
| 2019 |
Stutzmann GE. P4-501: EARLY-STAGE DEFECTS IN LYSOSOMAL FUNCTIONS INITIATE PROTEIN MISHANDLING IN NEURONS FROM AD MOUSE MODELS AND NEURONS FROM HUMAN PATIENTS Alzheimer's & Dementia. 15: P1505-P1505. DOI: 10.1016/j.jalz.2019.08.047 |
0.01 |
|
| 2019 |
Shim SS, Littlefield AM, Kapecki N, Briggs C, Stutzmann GE. P1-182: LITHIUM SUPPRESSES CALCIUM SIGNALING, NITROSATIVE STRESS AND TAUOPATHY AND ENHANCES SYNAPTIC PLASTICITY IN 3XTG-AD MICE Alzheimer's & Dementia. 15: P306-P306. DOI: 10.1016/j.jalz.2019.06.737 |
0.01 |
|
| 2018 |
Padovan-Neto FE, Jurkowski L, Murray C, Stutzmann GE, Kwan M, Ghavami A, Beaumont V, Park LC, West AR. Age- and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington's disease. Nitric Oxide : Biology and Chemistry. PMID 30528913 DOI: 10.1016/J.Niox.2018.12.002 |
0.01 |
|
| 2018 |
Mustaly S, Littlefield A, Stutzmann GE. Calcium Signaling Deficits in Glia and Autophagic Pathways Contributing to Neurodegenerative Disease. Antioxidants & Redox Signaling. PMID 29634342 DOI: 10.1089/ars.2017.7266 |
0.01 |
|
| 2018 |
Schrank S, Briggs C, McDaid J, Maigler K, Marr R, Stutzmann GE. P3-074: Human Induced Neurons Model Hallmarks Of Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1430 |
0.01 |
|
| 2018 |
Shim S, Kapecki N, Briggs C, Stutzmann G. S3. Lithium Treatment Suppresses Intracellular Calcium Signaling and Blocks Nitrosative Stress and Tauopathy in the Hippocampus of 3xTg Alzheimer's Disease Model Mice Biological Psychiatry. 83: S347-S348. DOI: 10.1016/j.biopsych.2018.02.894 |
0.01 |
|
| 2017 |
Lacampagne A, Liu X, Reiken S, Bussiere R, Meli AC, Lauritzen I, Teich AF, Zalk R, Saint N, Arancio O, Bauer C, Duprat F, Briggs CA, Chakroborty S, Stutzmann GE, et al. Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits. Acta Neuropathologica. PMID 28631094 DOI: 10.1007/S00401-017-1733-7 |
0.01 |
|
| 2017 |
Stutzmann GE, Hartley D. [F4–06–01]: UPDATE OF THE CALCIUM HYPOTHESIS: A FRAMEWORK FOR INTEGRATING NEW EVIDENCE INTO A COMPREHENSIVE THEORY OF PATHOGENESIS Alzheimer's & Dementia. 13. DOI: 10.1016/j.jalz.2017.07.394 |
0.01 |
|
| 2016 |
Briggs CA, Chakroborty S, Stutzmann GE. Emerging pathways driving early synaptic pathology in Alzheimer's disease. Biochemical and Biophysical Research Communications. PMID 27659710 DOI: 10.1016/J.Bbrc.2016.09.088 |
0.01 |
|
| 2016 |
Christian DT, Wang X, Chen EL, Sehgal LK, Ghassemlou MN, Miao JJ, Estepanian D, Araghi CH, Stutzmann GE, Wolf ME. Dynamic Alterations of Rat Nucleus Accumbens Dendritic Spines over two Months of Abstinence from Extended-Access Cocaine Self-Administration. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27555380 DOI: 10.1038/Npp.2016.168 |
0.01 |
|
| 2016 |
Shim SS, Stutzmann GE. Inhibition of Glycogen Synthase Kinase-3: An Emerging Target in the Treatment of Traumatic Brain Injury. Journal of Neurotrauma. PMID 26979735 DOI: 10.1089/neu.2015.4177 |
0.01 |
|
| 2016 |
Hinrich AJ, Jodelka FM, Chang JL, Brutman D, Bruno AM, Briggs CA, James BD, Stutzmann GE, Bennett DA, Miller SA, Rigo F, Marr RA, Hastings ML. Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides. Embo Molecular Medicine. PMID 26902204 DOI: 10.15252/Emmm.201505846 |
0.01 |
|
| 2016 |
Stutzmann GE. P1‐140: Targeting Early Calcium‐Mediated Pathology for AD Therapuetics Alzheimer's & Dementia. 12. DOI: 10.1016/j.jalz.2016.06.888 |
0.01 |
|
| 2015 |
Chakroborty S, Kim J, Schneider C, West AR, Stutzmann GE. Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer's disease mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 6893-902. PMID 25926464 DOI: 10.1523/Jneurosci.4002-14.2015 |
0.01 |
|
| 2015 |
Stutzmann GE. O1‐11‐01: Targeting calcium channels as a novel therapeutic strategy for Alzheimer's disease: Preventing pathology from molecular to network levels Alzheimer's & Dementia. 11. DOI: 10.1016/j.jalz.2015.07.087 |
0.01 |
|
| 2014 |
Chakroborty S, Stutzmann GE. Calcium channelopathies and Alzheimer's disease: insight into therapeutic success and failures. European Journal of Pharmacology. 739: 83-95. PMID 24316360 DOI: 10.1016/J.Ejphar.2013.11.012 |
0.01 |
|
| 2013 |
Briggs CA, Schneider C, Richardson JC, Stutzmann GE. β amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice. Neurobiology of Aging. 34: 1632-43. PMID 23337342 DOI: 10.1016/j.neurobiolaging.2012.12.013 |
0.01 |
|
| 2012 |
Chakroborty S, Briggs C, Miller MB, Goussakov I, Schneider C, Kim J, Wicks J, Richardson JC, Conklin V, Cameransi BG, Stutzmann GE. Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease. Plos One. 7: e52056. PMID 23284867 DOI: 10.1371/Journal.Pone.0052056 |
0.01 |
|
| 2012 |
Ferrario CR, Goussakov I, Stutzmann GE, Wolf ME. Withdrawal from cocaine self-administration alters NMDA receptor-mediated Ca2+ entry in nucleus accumbens dendritic spines. Plos One. 7: e40898. PMID 22870207 DOI: 10.1371/Journal.Pone.0040898 |
0.01 |
|
| 2012 |
Chakroborty S, Kim J, Schneider C, Jacobson C, Molgó J, Stutzmann GE. Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 8341-53. PMID 22699914 DOI: 10.1523/Jneurosci.0936-12.2012 |
0.01 |
|
| 2012 |
Bruno AM, Huang JY, Bennett DA, Marr RA, Hastings ML, Stutzmann GE. Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging. 33: 1001.e1-6. PMID 21531043 DOI: 10.1016/J.Neurobiolaging.2011.03.011 |
0.01 |
|
| 2011 |
Chakroborty S, Stutzmann GE. Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction. Science China. Life Sciences. 54: 752-62. PMID 21786198 DOI: 10.1007/S11427-011-4205-7 |
0.01 |
|
| 2011 |
Stutzmann GE, Mattson MP. Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease. Pharmacological Reviews. 63: 700-27. PMID 21737534 DOI: 10.1124/Pr.110.003814 |
0.01 |
|
| 2011 |
Goussakov I, Chakroborty S, Stutzmann GE. Generation of dendritic Ca2+ oscillations as a consequence of altered ryanodine receptor function in AD neurons. Channels (Austin, Tex.). 5: 9-13. PMID 21139422 DOI: 10.4161/Chan.5.1.14124 |
0.01 |
|
| 2011 |
Perez MF, Ford KA, Goussakov I, Stutzmann GE, Hu XT. Repeated cocaine exposure decreases dopamine D₂-like receptor modulation of Ca(2+) homeostasis in rat nucleus accumbens neurons. Synapse (New York, N.Y.). 65: 168-80. PMID 20665696 DOI: 10.1002/Syn.20831 |
0.01 |
|
| 2011 |
Goussakov I, Chakroborty S, Stutzmann GE. Generation of dendritic Ca 2+ oscillations as a consequence of altered ryanodine receptor function in AD neurons Channels. 5: 9-13. |
0.01 |
|
| 2010 |
Goussakov I, Miller MB, Stutzmann GE. NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 12128-37. PMID 20826675 DOI: 10.1523/Jneurosci.2474-10.2010 |
0.01 |
|
| 2010 |
Demuro A, Parker I, Stutzmann GE. Calcium signaling and amyloid toxicity in Alzheimer disease. The Journal of Biological Chemistry. 285: 12463-8. PMID 20212036 DOI: 10.1074/Jbc.R109.080895 |
0.01 |
|
| 2010 |
Stutzmann GE, Chakroborty S, Goussakov I, Miller M. P2-335: Neuronal signaling mechanisms underlying synaptic deficits in Alzheimer's Alzheimer's & Dementia. 6: S411-S412. DOI: 10.1016/J.Jalz.2010.05.1386 |
0.01 |
|
| 2009 |
Chakroborty S, Goussakov I, Miller MB, Stutzmann GE. Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 9458-70. PMID 19641109 DOI: 10.1523/Jneurosci.2047-09.2009 |
0.01 |
|
| 2008 |
Stutzmann G. Seeing the brain in action: how multiphoton imaging has advanced our understanding of neuronal function. Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada. 14: 482-91. PMID 18986602 DOI: 10.1017/S143192760808080X |
0.01 |
|
| 2008 |
Chakroborty S, Goussakov I, Aumiller B, Huang JY, Stutzmann GE. P4-271: Relative contribution of ER calcium channels to synaptic activity and plasticity in mutant PS1 Alzheimer's disease mouse models Alzheimer's & Dementia. 4: T750-T751. DOI: 10.1016/J.Jalz.2008.05.2340 |
0.01 |
|
| 2008 |
Goussakov I, Stutzmann G. P4-270: Linking ER calcium signaling disruptions to synaptic alterations in Alzheimer's disease Alzheimer's & Dementia. 4: T750-T750. DOI: 10.1016/J.Jalz.2008.05.2339 |
0.01 |
|
| 2008 |
Stutzmann G. S1‐03–06: Deviant neuronal calcium signaling and early synaptic deficits in Alzheimer's disease Alzheimer's & Dementia. 4. DOI: 10.1016/j.jalz.2008.05.202 |
0.01 |
|
| 2007 |
Stutzmann GE. The pathogenesis of Alzheimers disease is it a lifelong "calciumopathy"? The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 13: 546-59. PMID 17901262 DOI: 10.1177/1073858407299730 |
0.01 |
|
| 2007 |
Stutzmann GE, Smith I, Caccamo A, Oddo S, Parker I, Laferla F. Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models. Annals of the New York Academy of Sciences. 1097: 265-77. PMID 17413028 DOI: 10.1196/Annals.1379.025 |
0.01 |
|
| 2006 |
Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM, Parker I. Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 5180-9. PMID 16687509 DOI: 10.1523/Jneurosci.0739-06.2006 |
0.01 |
|
| 2006 |
Stutzmann GE. Multi-photon imaging in live cells: A close look at recent advances Microscopy and Microanalysis. 12: 8-9. DOI: 10.1017/S1431927606062155 |
0.01 |
|
| 2006 |
Mustaly SH, Garstka M, Kapecki N, Beaman KD, Gilman-Sachs A, McDaid J, Schrank S, Marr R, Stutzmann GE. P1-216: LYSOSOME-AUTOPHAGOSOME DEFECTS MEDIATE PROTEINOPATHY AND SYNAPTIC PATHOPHYSIOLOGY IN EARLY STAGES OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P361-P361. DOI: 10.1016/J.Jalz.2018.06.221 |
0.01 |
|
| 2006 |
Stutzmann GE, Smith I, Caccamo A, Oddo S, LaFerla F, Parker I. P1-125: Enhanced ryanodine receptor recruitment contributes to Ca2+
disruptions in young, adult and aged Alzheimer disease mice Alzheimer's & Dementia. 2: S132-S132. DOI: 10.1016/J.Jalz.2006.05.501 |
0.01 |
|
| 2005 |
Stutzmann GE. Calcium dysregulation, IP3 signaling, and Alzheimer's disease. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 11: 110-5. PMID 15746379 DOI: 10.1177/1073858404270899 |
0.01 |
|
| 2005 |
Stutzmann GE, Parker I. Dynamic multiphoton imaging: a live view from cells to systems. Physiology (Bethesda, Md.). 20: 15-21. PMID 15653835 DOI: 10.1152/Physiol.00028.2004 |
0.01 |
|
| 2004 |
Stutzmann GE, Caccamo A, LaFerla FM, Parker I. Dysregulated IP3 signaling in cortical neurons of knock-in mice expressing an Alzheimer's-linked mutation in presenilin1 results in exaggerated Ca2+ signals and altered membrane excitability. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 508-13. PMID 14724250 DOI: 10.1523/Jneurosci.4386-03.2004 |
0.01 |
|
| 2003 |
Stutzmann GE, LaFerla FM, Parker I. Ca2+ signaling in mouse cortical neurons studied by two-photon imaging and photoreleased inositol triphosphate. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 758-65. PMID 12574404 |
0.01 |
|
| 2001 |
Stutzmann GE, Marek GJ, Aghajanian GK. Adenosine preferentially suppresses serotonin2A receptor-enhanced excitatory postsynaptic currents in layer V neurons of the rat medial prefrontal cortex. Neuroscience. 105: 55-69. PMID 11483300 DOI: 10.1016/S0306-4522(01)00170-1 |
0.01 |
|
| 2001 |
Marchant JS, Stutzmann GE, Leissring MA, LaFerla FM, Parker I. Multiphoton-evoked color change of DsRed as an optical highlighter for cellular and subcellular labeling. Nature Biotechnology. 19: 645-9. PMID 11433276 DOI: 10.1038/90249 |
0.01 |
|
| 1999 |
Stutzmann GE, LeDoux JE. GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: RC8. PMID 10341269 DOI: 10.1523/Jneurosci.19-11-J0005.1999 |
0.01 |
|
| 1998 |
Stutzmann GE, McEwen BS, LeDoux JE. Serotonin modulation of sensory inputs to the lateral amygdala: dependency on corticosterone. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 9529-38. PMID 9801389 DOI: 10.1523/Jneurosci.18-22-09529.1998 |
0.01 |
|
| 1996 |
Li XF, Stutzmann GE, LeDoux JE. Convergent but temporally separated inputs to lateral amygdala neurons from the auditory thalamus and auditory cortex use different postsynaptic receptors: in vivo intracellular and extracellular recordings in fear conditioning pathways. Learning & Memory (Cold Spring Harbor, N.Y.). 3: 229-42. PMID 10456093 DOI: 10.1101/Lm.3.2-3.229 |
0.01 |
|
| 1996 |
Minabe Y, Emori K, Toor A, Stutzmann GE, Ashby CR. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study. Synapse (New York, N.Y.). 22: 35-45. PMID 8822476 DOI: 10.1002/(SICI)1098-2396(199601)22:1<35::AID-SYN4>3.0.CO;2-J |
0.01 |
|
| Hide low-probability matches. |